Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wilkins

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Veterinary Microbiology|August 30, 1991
In vitro susceptibility of rabbit strains of Clostridium spiroforme to antimicrobial agentsR J Carman, T D Wilkins
Current Topics in Microbiology and Immunology|September 12, 2000
Genetics of Clostridium difficile toxinsJ S Moncrief, T D Wilkins
Applied Microbiology|November 1, 1975
Development of a micromethod for identification of anaerobic bacteriaT D Wilkins, C B Walker
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2004
An unusual cause of dysphagiaS Payne, D Wilkins, R Howard
Archives of Oral Biology|January 1, 1976
Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in miceA S Hackman, T D Wilkins
Infection and Immunity|January 1, 1982
Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studiesJ M Libby, T D Wilkins
The Journal of Antimicrobial Chemotherapy|June 1, 1985
Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteriaC L Wells, T D Wilkins
Journal of Clinical Microbiology|March 1, 1986
Commercial latex test for Clostridium difficile toxin A does not detect toxin AD M Lyerly, T D Wilkins
Journal of Clinical Microbiology|February 8, 2003
Clostridium difficile testing: after 20 years, still challengingTracy D Wilkins, David M Lyerly
Antimicrobial Agents and Chemotherapy|June 1, 1974
Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in miceT D Wilkins, L D Smith
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Veterinary Microbiology|August 30, 1991
In vitro susceptibility of rabbit strains of Clostridium spiroforme to antimicrobial agentsR J Carman, T D Wilkins
Current Topics in Microbiology and Immunology|September 12, 2000
Genetics of Clostridium difficile toxinsJ S Moncrief, T D Wilkins
Applied Microbiology|November 1, 1975
Development of a micromethod for identification of anaerobic bacteriaT D Wilkins, C B Walker
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2004
An unusual cause of dysphagiaS Payne, D Wilkins, R Howard
Archives of Oral Biology|January 1, 1976
Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in miceA S Hackman, T D Wilkins
Infection and Immunity|January 1, 1982
Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studiesJ M Libby, T D Wilkins
The Journal of Antimicrobial Chemotherapy|June 1, 1985
Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteriaC L Wells, T D Wilkins
Journal of Clinical Microbiology|March 1, 1986
Commercial latex test for Clostridium difficile toxin A does not detect toxin AD M Lyerly, T D Wilkins
Journal of Clinical Microbiology|February 8, 2003
Clostridium difficile testing: after 20 years, still challengingTracy D Wilkins, David M Lyerly
Antimicrobial Agents and Chemotherapy|June 1, 1974
Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in miceT D Wilkins, L D Smith
Pageof 28